28.03.2011 • News3iAzelisChemical Distribution

3i Kicks Off Azelis Chemicals Sale

British private equity firm 3i Group has kicked off the sale of Azelis, a Belgium headquartered chemicals distributor with €1 billion euros in sales, people familiar with the situation said.

London-listed 3i has hired Bank of America Merrill Lynch to sell the company, which it acquired in 2007 in a €315 million deal, two people said.

The firm hopes to run a tightly controlled auction process, focusing on potential trade buyers, one of those people said. 3i declined to comment.

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.